These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33314436)

  • 21. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
    Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok JB
    Neurology; 2012 Sep; 79(10):995-1001. PubMed ID: 22875086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.
    Cruchaga C; Graff C; Chiang HH; Wang J; Hinrichs AL; Spiegel N; Bertelsen S; Mayo K; Norton JB; Morris JC; Goate A
    Arch Neurol; 2011 May; 68(5):581-6. PubMed ID: 21220649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
    Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical astroglial pTDP-43 pathology in astroglial predominant tauopathy.
    Gelpi E; Aldecoa I; Lopez-Villegas D; Abellan-Vidal MT; Mercadel-Fañanas P; Fortea J; Ribosa R; Morenas E; Gomez-Anson B; Molina-Porcel L; Ximelis T; Borrego S; Antonell A; Rovelet-Lecrux A; Klotz S; Andres-Benito P; Sanchez-Valle R; Ferrer I
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1109-1113. PubMed ID: 33730418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene-Specific Effects on Brain Volume and Cognition of
    Vandebergh M; Ramos EM; Corriveau-Lecavalier N; Ramanan VK; Kornak J; Mester C; Kolander T; Brushaber DE; Staffaroni AM; Geschwind DH; Wolf AA; Kantarci K; Gendron T; Petrucelli L; Van den Broeck M; Wynants S; Baker M; Borrego-Écija S; Appleby B; Barmada S; Bozoki AC; Clark D; Darby RR; Dickerson BC; Domoto-Reilly K; Fields JA; Galasko D; Ghoshal N; Graff-Radford NR; Grant IM; Honig LS; Hsiung GR; Huey ED; Irwin DJ; Knopman DS; Kwan JY; Léger GC; Litvan I; Masdeu JC; Mendez MF; Onyike CU; Pascual B; Pressman PS; Ritter A; Roberson ED; Snyder A; Sullivan AC; Tartaglia MC; Wint D; Heuer HW; Forsberg LK; Boxer AL; Rosen HJ; Boeve BF; Rademakers R;
    Neurology; 2024 Oct; 103(8):e209832. PubMed ID: 39321401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort.
    van der Zee J; Van Langenhove T; Kleinberger G; Sleegers K; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Joris G; Brys J; Mattheijssens M; Peeters K; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    Brain; 2011 Mar; 134(Pt 3):808-15. PubMed ID: 21354975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function.
    Brady OA; Zheng Y; Murphy K; Huang M; Hu F
    Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis.
    Rollinson S; Mead S; Snowden J; Richardson A; Rohrer J; Halliwell N; Usher S; Neary D; Mann D; Hardy J; Pickering-Brown S
    Neurobiol Aging; 2011 Apr; 32(4):758.e1-7. PubMed ID: 21257233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.
    Premi E; Grassi M; van Swieten J; Galimberti D; Graff C; Masellis M; Tartaglia C; Tagliavini F; Rowe JB; Laforce R; Finger E; Frisoni GB; de Mendonça A; Sorbi S; Gazzina S; Cosseddu M; Archetti S; Gasparotti R; Manes M; Alberici A; Cardoso MJ; Bocchetta M; Cash DM; Ourselin S; Padovani A; Rohrer JD; Borroni B;
    Brain; 2017 Jun; 140(6):1784-1791. PubMed ID: 28460069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice.
    Feng T; Du H; Yang C; Wang Y; Hu F
    Acta Neuropathol; 2024 Mar; 147(1):62. PubMed ID: 38526799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum.
    Carbayo Á; Borrego-Écija S; Turon-Sans J; Cortés-Vicente E; Molina-Porcel L; Gascón-Bayarri J; Rubio MÁ; Povedano M; Gámez J; Sotoca J; Juntas-Morales R; Almendrote M; Marquié M; Sánchez-Valle R; Illán-Gala I; Dols-Icardo O; Rubio-Guerra S; Bernal S; Caballero-Ávila M; Vesperinas A; Gelpi E; Rojas-García R
    Brain; 2024 Jul; 147(7):2357-2367. PubMed ID: 38227807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of TMEM106B rs1990622 marker and frontotemporal dementia: evidence for a recessive effect and meta-analysis.
    Hernández I; Rosende-Roca M; Alegret M; Mauleón A; Espinosa A; Vargas L; Sotolongo-Grau O; Tárraga L; Boada M; Ruiz A
    J Alzheimers Dis; 2015; 43(1):325-34. PubMed ID: 25096617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants.
    Borrego-Écija S; Turon-Sans J; Ximelis T; Aldecoa I; Molina-Porcel L; Povedano M; Rubio MA; Gámez J; Cano A; Paré-Curell M; Bajo L; Sotoca J; Clarimón J; Balasa M; Antonell A; Lladó A; Sánchez-Valle R; Rojas-García R; Gelpi E
    Brain Pathol; 2021 May; 31(3):e12942. PubMed ID: 33576076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
    Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMEM106B a novel risk factor for frontotemporal lobar degeneration.
    van der Zee J; Van Broeckhoven C
    J Mol Neurosci; 2011 Nov; 45(3):516-21. PubMed ID: 21614538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TMEM106B Fibrils from FTLD Patients and Healthy Controls.
    Greenwood JD; Powell WC; Walczak MA
    ACS Chem Neurosci; 2023 Aug; 14(16):2827-2829. PubMed ID: 37530644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
    Tropea TF; Mak J; Guo MH; Xie SX; Suh E; Rick J; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Trojanowski JQ; Van Deerlin V; Chen-Plotkin AS
    Ann Neurol; 2019 Jun; 85(6):801-811. PubMed ID: 30973966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
    Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
    J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.